Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients

Background: Recent studies showed a high frequency of low bone mineral density (BMD) in HIV-infected patients and no reports have been issued in Turkey. Our aim was to evaluate BMD and risk factors for osteopenia/osteoporosis in HIV-infected patients that attended an outpatient clinic in Istanbul, T...

Full description

Bibliographic Details
Main Authors: Ozlem Altuntas Aydın, Hayat Kumbasar Karaosmanoglu, Rıdvan Karahasanoglu, Meryem Tahmaz, Ozcan Nazlıcan
Format: Article
Language:English
Published: Elsevier 2013-11-01
Series:Brazilian Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867013002195
_version_ 1818532046978416640
author Ozlem Altuntas Aydın
Hayat Kumbasar Karaosmanoglu
Rıdvan Karahasanoglu
Meryem Tahmaz
Ozcan Nazlıcan
author_facet Ozlem Altuntas Aydın
Hayat Kumbasar Karaosmanoglu
Rıdvan Karahasanoglu
Meryem Tahmaz
Ozcan Nazlıcan
author_sort Ozlem Altuntas Aydın
collection DOAJ
description Background: Recent studies showed a high frequency of low bone mineral density (BMD) in HIV-infected patients and no reports have been issued in Turkey. Our aim was to evaluate BMD and risk factors for osteopenia/osteoporosis in HIV-infected patients that attended an outpatient clinic in Istanbul, Turkey. Method: In order to determine the prevalence of BMD, 126 HIV-infected patients had been studied with dual energy X-ray absorptiometry (DEXA). The association between BMD and age, gender, body mass index (BMI), habits, 25(OH)vitamin D, HIV RNA, CD4 lymphocyte nadir, using and duration of highly active antiretroviral treatment (HAART) were investigated by using multivariate analysis. Results: Median age was 40.1 years (range, 20–70); 84% were male; 35.7% patients had AIDS, 63.5% were treated with HAART. Osteopenia and osteoporosis were diagnosed in 53.9% and 23.8%, respectively. Mean plasma HIV RNA was 5.2 (SD 1.0) log10 copies/mL and CD4 lymphocyte nadir was 313.8 (SD 226.2)/mm3. Factors associated with bone loss were high viral load (p = 0.034), using (p = 0.033) and duration of HAART (p = 0.008). No correlation had been seen between sex and osteopenia/osteoporosis (p = 0.794). However, males showed higher rates of osteoporosis than females (p = 0.042). Conclusions: Our results show a very high prevalence of bone mass reduction in Turkish HIV-infected patients. This study supports the importance of both HIV and antiretroviral therapy in low BMD. Keywords: Osteopenia/osteoporosis, HIV/AIDS, Prevalence, Risk factors
first_indexed 2024-12-11T17:40:25Z
format Article
id doaj.art-afacda9c4a4247c495ae2def8c86b477
institution Directory Open Access Journal
issn 1413-8670
language English
last_indexed 2024-12-11T17:40:25Z
publishDate 2013-11-01
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-afacda9c4a4247c495ae2def8c86b4772022-12-22T00:56:33ZengElsevierBrazilian Journal of Infectious Diseases1413-86702013-11-01176707711Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patientsOzlem Altuntas Aydın0Hayat Kumbasar Karaosmanoglu1Rıdvan Karahasanoglu2Meryem Tahmaz3Ozcan Nazlıcan4Haseki Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Istanbul, Turkey; Corresponding author at: Haseki Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Aksaray, Fatıh, Istanbul, Turkey.Haseki Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Istanbul, TurkeyHaseki Training and Research Hospital, Radiology, Istanbul, TurkeyHaseki Training and Research Hospital, Internal Medicine, Istanbul, TurkeyHaseki Training and Research Hospital, Infectious Diseases and Clinical Microbiology, Istanbul, TurkeyBackground: Recent studies showed a high frequency of low bone mineral density (BMD) in HIV-infected patients and no reports have been issued in Turkey. Our aim was to evaluate BMD and risk factors for osteopenia/osteoporosis in HIV-infected patients that attended an outpatient clinic in Istanbul, Turkey. Method: In order to determine the prevalence of BMD, 126 HIV-infected patients had been studied with dual energy X-ray absorptiometry (DEXA). The association between BMD and age, gender, body mass index (BMI), habits, 25(OH)vitamin D, HIV RNA, CD4 lymphocyte nadir, using and duration of highly active antiretroviral treatment (HAART) were investigated by using multivariate analysis. Results: Median age was 40.1 years (range, 20–70); 84% were male; 35.7% patients had AIDS, 63.5% were treated with HAART. Osteopenia and osteoporosis were diagnosed in 53.9% and 23.8%, respectively. Mean plasma HIV RNA was 5.2 (SD 1.0) log10 copies/mL and CD4 lymphocyte nadir was 313.8 (SD 226.2)/mm3. Factors associated with bone loss were high viral load (p = 0.034), using (p = 0.033) and duration of HAART (p = 0.008). No correlation had been seen between sex and osteopenia/osteoporosis (p = 0.794). However, males showed higher rates of osteoporosis than females (p = 0.042). Conclusions: Our results show a very high prevalence of bone mass reduction in Turkish HIV-infected patients. This study supports the importance of both HIV and antiretroviral therapy in low BMD. Keywords: Osteopenia/osteoporosis, HIV/AIDS, Prevalence, Risk factorshttp://www.sciencedirect.com/science/article/pii/S1413867013002195
spellingShingle Ozlem Altuntas Aydın
Hayat Kumbasar Karaosmanoglu
Rıdvan Karahasanoglu
Meryem Tahmaz
Ozcan Nazlıcan
Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
Brazilian Journal of Infectious Diseases
title Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
title_full Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
title_fullStr Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
title_full_unstemmed Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
title_short Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients
title_sort prevalence and risk factors of osteopenia osteoporosis in turkish hiv aids patients
url http://www.sciencedirect.com/science/article/pii/S1413867013002195
work_keys_str_mv AT ozlemaltuntasaydın prevalenceandriskfactorsofosteopeniaosteoporosisinturkishhivaidspatients
AT hayatkumbasarkaraosmanoglu prevalenceandriskfactorsofosteopeniaosteoporosisinturkishhivaidspatients
AT rıdvankarahasanoglu prevalenceandriskfactorsofosteopeniaosteoporosisinturkishhivaidspatients
AT meryemtahmaz prevalenceandriskfactorsofosteopeniaosteoporosisinturkishhivaidspatients
AT ozcannazlıcan prevalenceandriskfactorsofosteopeniaosteoporosisinturkishhivaidspatients